Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
House panel weighs $10,000 fiscal study for insurance coverage of biomarker testing; members question scope and longevity
Summary
A strike‑all draft of S.154 would direct the Department of Financial Regulation and Agency of Human Services to estimate the cost of requiring insurers and Medicaid to cover biomarker testing; the draft includes a $10,000 appropriation for DFR, and lawmakers questioned how DFR/AHS would determine which tests to cost and whether the study could be quickly outdated.
A committee staff presenter described a strike‑all amendment to S.154 on April 14 that would require the Department of Financial Regulation (DFR) and the Agency of Human Services (AHS) to analyze the costs of requiring health insurers and Medicaid to cover biomarker testing that is supported by medical and scientific evidence. The draft includes a $10,000 appropriation to DFR in fiscal year 2027 for that analysis.
"It's asking them to come back with an estimated amount that insurance premiums would increase and what it would cost for Medicaid if…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
